.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Predict branded drug patent expiration
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
Healthtrust
McKesson
Chubb
Dow
Chinese Patent Office
Merck
Fish and Richardson
Deloitte
Mallinckrodt

Generated: June 27, 2017

DrugPatentWatch Database Preview

LENTE ILETIN II Drug Profile

« Back to Dashboard

Which patents cover Lente Iletin Ii, and when can generic versions of Lente Iletin Ii launch?

Lente Iletin Ii is a drug marketed by Lilly and is included in two NDAs.

The generic ingredient in LENTE ILETIN II is insulin zinc susp purified pork. There are thirty-eight drug master file entries for this compound. Additional details are available on the insulin zinc susp purified pork profile page.

Summary for Tradename: LENTE ILETIN II

Patents:0
Applicants:1
NDAs:2
Clinical Trials: see list3
Drug Prices:see details
DailyMed Link:LENTE ILETIN II at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lilly
LENTE ILETIN II
insulin zinc susp purified beef
INJECTABLE;INJECTION018477-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Lilly
LENTE ILETIN II (PORK)
insulin zinc susp purified pork
INJECTABLE;INJECTION018347-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
US Department of Justice
McKinsey
UBS
Express Scripts
Cipla
Mallinckrodt
AstraZeneca
QuintilesIMS
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot